journal article·2026-04-01Open access

Dendrimer Nanogels with Built-in Free Radical Scavenging Enable Efficient Topical Delivery of a Hydrophilic Antioxidant to Restore Lens Redox Balance for Cataract Treatment

Lin Qi, Huari Kou, Anna Chernatynskaya, Da Huang, Vimalin Jeyalatha Mani, Humeyra Karacal, Nuran Ercal, Hu Yang

ACS Applied Materials & Interfaces· Volume 18· Issue 12

Abstract

High Resolution Image Download MS PowerPoint Slide Cataract is a leading cause of vision impairment worldwide and are primarily caused by oxidative stress that damages and aggregates lens proteins, leading to lens opacification. However, the eye’s anatomical barriers limit the penetration and bioavailability of antioxidant therapies. To address this challenge, a dendrimer-based nanogel with a built-in reactive oxygen species (ROS)-scavenging capability developed by us was employed to deliver the antioxidant N-acetylcysteine (NAC) to the lens. NAC was loaded into a generation-5 PEGylated poly(amidoamine) dendrimer (G5-PEG-TK, termed the GPT) nanogel. The resulting NAC-GPT was characterized for its ROS-scavenging activity, bioavailability, and corneal permeability. The efficacy of NAC-GPT was evaluated ex vivo and in vivo using a sodium selenite (Na 2 SeO 3 )-induced cataract model. Both ex vivo and in vivo results demonstrated that NAC-GPT significantly increased the level of NAC accumulation in the lens. Furthermore, the in vivo study shows that NAC-GPT significantly increased the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG), an indicator of redox balance restoration. In particular, the GSH/GSSG ratio in NAC-GPT–treated lenses was nearly 2-fold higher than that of the untreated cataract control. These findings indicate that the GPT nanogel platform can effectively deliver antioxidants to the eye and is a promising noninvasive antioxidant delivery strategy with the ability to restore redox balance in cataract.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Sulfur Compounds in Biology · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Joint Department of Biomedical Engineering

Marquette University and Medical College of Wisconsin

Linda and Bipin Doshi Department of Chemical and Biochemical Engineering

Missouri University of Science and Technology

College of Biological Science and Engineering

Fuzhou University

Premiere Eye Associates, 816 S. Kirkwood, St. Louis, Missouri 63122, United States

Department of Chemistry

Funding

National Institutes of Health (NIH)

References (41)

Show source-provided references
1. 10.1016/S2214-109X(17)30393-510.1016/S2214-109X(17)30393-5 ↗
2. 10.21037/atm-20-420710.21037/atm-20-4207 ↗
3. Yorston D. · Community Eye Health J. · 2008 · 21 · 1
4. 10.1016/j.exer.2016.05.02710.1016/j.exer.2016.05.027 ↗
5. 10.1167/tvst.9.8.3710.1167/tvst.9.8.37 ↗
6. 10.3390/antiox1310119310.3390/antiox13101193 ↗
7. 10.3390/antiox1310124910.3390/antiox13101249 ↗
8. 10.1016/j.redox.2023.10296710.1016/j.redox.2023.102967 ↗
9. 10.3390/nu1105118610.3390/nu11051186 ↗
10. 10.3109/10715762.2013.77715510.3109/10715762.2013.777155 ↗
11. Wang P. · Mol. Vis. · 2009 · 15 · 2945
12. Maddirala S. K. Y. · 2015
13. 10.3390/gels802008210.3390/gels8020082 ↗
14. 10.1016/j.ijpharm.2021.12092410.1016/j.ijpharm.2021.120924 ↗
15. 10.1111/ceo.1380110.1111/ceo.13801 ↗
16. 10.1016/j.addr.2018.03.00910.1016/j.addr.2018.03.009 ↗
17. 10.1186/s12951-023-01992-210.1186/s12951-023-01992-2 ↗
18. 10.4236/abc.2022.12501510.4236/abc.2022.125015 ↗
19. 10.1186/s13036-022-00298-510.1186/s13036-022-00298-5 ↗
20. 10.1021/acs.biomac.5c0005010.1021/acs.biomac.5c00050 ↗
21. Yang H. · Google Patents · 2024
22. 10.1016/j.trsl.2017.10.00810.1016/j.trsl.2017.10.008 ↗
23. 10.1002/advs.20240164810.1002/advs.202401648 ↗
24. 10.1016/j.exer.2006.07.00910.1016/j.exer.2006.07.009 ↗
25. 10.1016/j.bbrep.2022.10121310.1016/j.bbrep.2022.101213 ↗
26. 10.1186/s12886-017-0443-110.1186/s12886-017-0443-1 ↗
27. Shearer T. R. · Mol. Vis. · 1997 · 3 · 8
28. 10.3390/antiox1101002410.3390/antiox11010024 ↗
29. 10.1371/journal.pone.021137610.1371/journal.pone.0211376 ↗
30. 10.1021/ac503456610.1021/ac5034566 ↗
31. 10.1016/j.ces.2022.11828310.1016/j.ces.2022.118283 ↗
32. 10.1021/acsami.5c0081610.1021/acsami.5c00816 ↗
33. 10.3390/molecules2306141910.3390/molecules23061419 ↗
34. 10.1080/10837450.2017.131513410.1080/10837450.2017.1315134 ↗
35. 10.1016/j.survophthal.2021.07.00810.1016/j.survophthal.2021.07.008 ↗
36. 10.1007/s11095-006-9122-210.1007/s11095-006-9122-2 ↗
37. 10.1007/s11095-012-0761-110.1007/s11095-012-0761-1 ↗
38. 10.1002/mba2.3010.1002/mba2.30 ↗
39. 10.1016/j.freeradbiomed.2018.07.01710.1016/j.freeradbiomed.2018.07.017 ↗
40. 10.3390/cells604003910.3390/cells6040039 ↗
41. 10.1016/j.exer.2016.11.00810.1016/j.exer.2016.11.008 ↗